• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2020 年新型冠状病毒病（COVID-19）患者抗栓治疗的循证实用指南。

Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.

机构信息

Hospital Christóvão da Gama, Grupo Leforte, Santo André, São Paulo, Brazil.

Santa Casa de Sao Paulo School of Medical Sciences, São Paulo, São Paulo, Brazil.

出版信息

Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620936350. doi: 10.1177/1076029620936350.

DOI:10.1177/1076029620936350
PMID:32649232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7357049/
Abstract

This practical guidance, endorsed by the Brazilian Society of Thrombosis and Hemostasis and The Brazilian Society of Angiology and Vascular Surgery, the International Union of Angiology and the European Venous Forum, aims to provide physicians with clear guidance, based on current best evidence-based data, on clinical strategies to manage antithrombotic strategies in patients with coronavirus disease 2019.

摘要

本实践指南由巴西血栓与止血学会、巴西血管外科学会、国际血管联盟和欧洲静脉论坛联合认可，旨在为临床医生提供明确的指导，依据的是目前最佳的循证数据，涉及管理 2019 冠状病毒病患者抗血栓策略的临床策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/9919c1880382/10.1177_1076029620936350-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/4b0a4c79e618/10.1177_1076029620936350-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/187ce8dbb74c/10.1177_1076029620936350-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/e83bfa347c63/10.1177_1076029620936350-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/aca33b2a03e4/10.1177_1076029620936350-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/c71aad56c56d/10.1177_1076029620936350-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/9919c1880382/10.1177_1076029620936350-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/4b0a4c79e618/10.1177_1076029620936350-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/187ce8dbb74c/10.1177_1076029620936350-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/e83bfa347c63/10.1177_1076029620936350-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/aca33b2a03e4/10.1177_1076029620936350-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/c71aad56c56d/10.1177_1076029620936350-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ec/7357049/9919c1880382/10.1177_1076029620936350-fig6.jpg

相似文献

1
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.2020 年新型冠状病毒病（COVID-19）患者抗栓治疗的循证实用指南。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620936350. doi: 10.1177/1076029620936350.
2
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.新冠肺炎癌症患者的血栓形成与止血问题
Semin Thromb Hemost. 2020 Oct;46(7):785-788. doi: 10.1055/s-0040-1714275. Epub 2020 Aug 12.
3
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.科学与标准化委员会通讯：新型冠状病毒肺炎住院患者静脉血栓栓塞症诊断、预防及治疗的临床指南
J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929.
4
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.2019冠状病毒病、血栓形成前因素与静脉血栓栓塞症
Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.
5
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.COVID-19：凝血功能障碍、血栓形成风险和抗凝治疗的理由。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620938149. doi: 10.1177/1076029620938149.
6
Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19.用于预防和管理新型冠状病毒肺炎血栓形成的药物治疗
Semin Thromb Hemost. 2020 Oct;46(7):789-795. doi: 10.1055/s-0040-1714273. Epub 2020 Aug 20.
7
Venous thromboembolism and COVID-19.静脉血栓栓塞与2019冠状病毒病
Respir Med Res. 2020 Nov;78:100759. doi: 10.1016/j.resmer.2020.100759. Epub 2020 Apr 28.
8
Immune-Mediated Coagulopathy in COVID-19 Infection.新型冠状病毒肺炎感染中的免疫介导性凝血病
Semin Thromb Hemost. 2020 Oct;46(7):838-840. doi: 10.1055/s-0040-1714272. Epub 2020 Sep 2.
9
Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy.新型冠状病毒肺炎：血液学异常与抗血栓治疗。
Tohoku J Exp Med. 2020 Aug;251(4):327-336. doi: 10.1620/tjem.251.327.
10
Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.2019年重症冠状病毒感染中高凝状态间接标志物与血栓弹力图的相关性
Thromb Res. 2020 Nov;195:69-71. doi: 10.1016/j.thromres.2020.07.013. Epub 2020 Jul 9.

引用本文的文献

1
The Italian public health response during the pandemic emergency: from qualitative data to the "performance index" of care provided by Spoleto Hospital.意大利在大流行紧急情况下的公共卫生应对措施：从定性数据到斯波莱托医院提供的护理“绩效指数”
Front Public Health. 2025 Jun 16;13:1337375. doi: 10.3389/fpubh.2025.1337375. eCollection 2025.
2
Prophylactic anticoagulants for non-hospitalised people with COVID-19.COVID-19 非住院患者的预防性抗凝治疗。
Cochrane Database Syst Rev. 2023 Aug 16;8(8):CD015102. doi: 10.1002/14651858.CD015102.pub2.
3
Diagnosis and management of patients with acute limb ischemia after Covid-19 infection: a case series.

本文引用的文献

1
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高：更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
2
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?新冠病毒感染中的肺栓塞或肺血栓形成？使用高剂量肝素进行血栓预防的建议是否合理？
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.
3
Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the Editors.
新型冠状病毒肺炎感染后急性肢体缺血患者的诊断与管理：病例系列
J Vasc Bras. 2022 Nov 25;21:e20220044. doi: 10.1590/1677-5449.202200441. eCollection 2022.
4
Anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的抗凝治疗。
Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2.
5
Rigorous Assessment of Guidelines on COVID-19-Related Thrombotic or Thromboembolic Disease: Implications for Clinical Practice of Prevention, Diagnosis, and Treatment.对新型冠状病毒肺炎相关血栓形成或血栓栓塞性疾病指南的严格评估：对预防、诊断和治疗临床实践的启示
Evid Based Complement Alternat Med. 2021 Sep 24;2021:5513744. doi: 10.1155/2021/5513744. eCollection 2021.
6
Severe COVID-19: understanding the role of immunity, endothelium, and coagulation in clinical practice.重症新型冠状病毒肺炎：了解免疫、内皮及凝血在临床实践中的作用
J Vasc Bras. 2020 Nov 16;19:e20200131. doi: 10.1590/1677-5449.200131.
7
Late mesenteric ischemia after Sars-Cov-2 infection: case report.新型冠状病毒感染后迟发性肠系膜缺血：病例报告
J Vasc Bras. 2021 Mar 15;20:e20200105. doi: 10.1590/1677-5449.200105.
8
Antithrombotic prophylaxis in children and adolescents' patients with SARS-CoV-2 (COVID-19) infection: A practical guidance for clinicians.儿童和青少年 SARS-CoV-2（COVID-19）感染患者的抗血栓预防：临床医生实用指南。
Acta Biomed. 2020 Nov 10;91(4):e2020170. doi: 10.23750/abm.v91i4.10720.
9
Prophylactic anticoagulants for people hospitalised with COVID-19.COVID-19 住院患者的预防性抗凝治疗。
Cochrane Database Syst Rev. 2020 Oct 2;10(10):CD013739. doi: 10.1002/14651858.CD013739.
10
The Role of the Endothelium in Severe COVID-19.内皮细胞在重症新型冠状病毒肺炎中的作用
Arq Bras Cardiol. 2020 Dec;115(6):1184-1189. doi: 10.36660/abc.20200643.
关于 2019 年冠状病毒病和心血管疾病的当前观点：编辑的白皮书。
J Am Heart Assoc. 2020 Jun 16;9(12):e017013. doi: 10.1161/JAHA.120.017013. Epub 2020 Apr 29.
4
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
5
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study.85 例武汉 COVID-19 死亡病例的临床特征。一项回顾性观察研究。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1372-1379. doi: 10.1164/rccm.202003-0543OC.
6
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
7
COVID-19 and Cardiovascular Disease.新型冠状病毒肺炎与心血管疾病。
Circulation. 2020 May 19;141(20):1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941. Epub 2020 Mar 21.
8
Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis.改良的IMPROVE VTE风险评分与升高的D-二聚体可识别急性病患者群体中高静脉血栓栓塞风险，以进行延长的血栓预防。
TH Open. 2020 Mar 13;4(1):e59-e65. doi: 10.1055/s-0040-1705137. eCollection 2020 Jan.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
New Approaches to Conducting Randomized Controlled Trials.进行随机对照试验的新方法。
J Am Coll Cardiol. 2020 Feb 11;75(5):556-559. doi: 10.1016/j.jacc.2019.11.043.